Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs ECL✓SelectedUSD · ECLMRNA vs ECL performance historyLatest closeAs of+1.29%11/19
Stock and ETF performance explorer

MRNA vs ECL

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-24.4%
ECL return
+36.2%
Excess return
-60.6%
Maximum drawdown
-93.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioECLExcessAlpha
1D+1.3%-1.1%+2.4%+2.1%
7D-13.8%-2.3%-11.5%-12.3%
30D-17.7%+3.2%-20.8%-19.4%
3M+14.3%+4.4%+9.9%+11.3%
6M+336.0%+21.6%+314.3%+288.2%
YTD+575.9%+14.2%+561.8%+526.3%
1Y+724.4%+14.9%+709.4%+660.7%
3Y+160.8%+66.3%+94.4%+88.7%
5Y-24.4%+33.9%-58.3%-58.1%
All-24.4%+36.2%-60.6%-58.1%

Cumulative growth

Daily Returns

Daily percentage return beside ECL.

Daily Out/Under-Performance

Portfolio return minus ECL return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × ECL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded ECL wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling